郑红云
检验
教学秘书，副教授，副主任技师，硕士生导师
教学秘书，副教授，副主任技师，硕士生导师
导师介绍
| 姓名 | 郑红云 |
| 出生年月 | 1980年10月 |
| 单位 | 武汉大学人民医院检验科 |
| 所属学科 | 临床实验诊断学 |
| 职务、职称及头衔 | 教学秘书，副教授，副主任技师，硕士生导师 |
| shenzheng2008@163.com | |
| 联系方式 | 027-88041911转81176或15972148283 |
| 研究方向 |
1.
肿瘤分子诊断与个体化医疗 2. 遗传病临床分子诊断 |
| 个人简介 | 从事肿瘤分子诊断、产前遗传病筛查与诊断等临床检测工作。已发表论文30余篇，发表SCI论文10余篇。主持科研课题4项，包括国家自然科学基金1项，中国博士后面上基金1项，湖北省自然科学基金1项等。参编分子诊断领域专著2本，获得武汉大学微课比赛、珞珈论坛教师论文三等奖。获武汉大学医学部教学项目1项，撰写教学论文3篇。2017年获湖北省科技进步二等奖，2018、2019年获“武汉大学人民医院优秀共产党员称号”。 |
| 学术任职与荣誉 |
中国医师协会检验医师分会青年委员 武汉市微循环学会常务理事 湖北省病理生理学会理事 武汉医院协会委员 |
| 教育履历 |
1999.09-2004.06武汉科技大学医学院临床医学专业本科生获学士学位 2004.09-2007.06华中科技大学同济医学院病理生理学硕士研究生获硕士学位 2007.09-2010.06华中科技大学同济医学院病理生理学博士研究生获博士学位 |
| 工作履历 |
2010.07-2011.11 武汉大学人民医院技师 2011.12-2014.11 武汉大学人民医院主管技师 2014.12-2021.2 武汉大学人民医院副主任技师 2021.3-至今 武汉大学人民医院检验科副教授 |
| 成果获奖 |
1.《基于Sanger法测序的分子诊断检测试剂盒研发及在个体化医疗中的应用》2016年获湖北省科技进步二等奖，排第七 2.《白血病精准医疗中分子诊断技术的研发与临床应用》2018年湖北省科技发明二等奖，排第六 |
| 代表性论著 |
(1) Zheng HY, Wang HB,
Shen FJ, Tong YQ, Yao Q, Qiao B, Sun S, Li Y*. EGFR Gene Mutation and
Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer.
Curr Med Sci. 2020;40(1):78-84. (2) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. Over expression of MALAT1 contributes to cervical cancer progression by acting as asponge of miR‐429. 2018. Journal of Cellular Physiology.2019; 234(7);11219-11226. (3) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer. Journal of Cellular Physiology. 2019;234(5):7004-7011. (4) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. LINC00657 expedites neuropathic pain development by modulating miR-136/ZEB1 axis in a rat model. Journal of cellular biochemistry. J Cell Biochem. 2019;120(1):1000-1010. (5) Hongyun Zheng, Fujin Shen, Yongqing Tong, Yan Li*. PP2A Inhibits cervical cancer cell migration by dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK signaling pathway. Curr Med Sci. 2018;38(1):115-123. (6) Zheng HY, Li Y*, Tong YQ, et al. A novel universal multiplex PCR improves detection of AZFc Y-chromosome microdeletions. Journal of Assisted Reproduction and Genetics. 2014; 31(5):613-20. (7) Zheng H, Li Y, Dai W, et al. Role of Endogenous Estrogen on the Incidence of Coronary Heart Disease in Men. Angiology. 2012; 63(8):591-6. (8) Zheng HY, Li Y*, Dai W, et al. Imbalance of testosterone/estradiol promotes male CHD development. Biomed Mater Eng. 2012; 22(1):179-85. (9) Zhu LQ#, Zheng HY#, Peng CX, Liu D, Li HL, Wang Q, Wang JZ*. Protein phosphatase 2A facilitates functional axonogenesis by dephosphorylating CRMP2. J Neurosci. 2010;30(10):3839-48. |
| Name | HONGYUN ZHENG |
| Date of birth | Oct，1980 |
| Department | Clinical Laboratory Department，Renmin Hospital,Wuhan University. |
| Title | Teaching secretary,Associate professor, master tutor |
| shenzheng2008@163.com | |
| TEL | 027-88041911-81176 or 15972148283 |
| Research Direction |
1.
Tumor molecular diagnosis and individualized medical treatment 2. Clinical molecular diagnosis of genetic diseases |
| Personal Profile | She engaged in tumor molecular diagnosis, prenatal genetic disease screening and diagnosis and other clinical testing work. More than 30 papers and 10 SCI papers have been published. He presided over 4 scientific research projects, including 1 National Natural Science Foundation of China, 1 China doctoral foundation, 1 Hubei Natural Science Foundation, etc. He participated in the editing of two monographs in the field of molecular diagnosis, and won the third prize in the micro lecture competition of Wuhan University and the teacher's thesis of Luojia forum. He won one teaching project of Wuhan University Medical Department and wrote three teaching papers. In 2017, he won the second prize of science and technology progress of Hubei Province, and in 2018 and 2019, he won the title of "Excellent Communist Party member of people's Hospital of Wuhan University". |
| Selected Publications |
(1) Zheng HY, Wang HB, Shen FJ, Tong YQ, Yao Q,
Qiao B, Sun S, Li Y*. EGFR Gene Mutation and Methodological Evaluation in 399
Patients with Non-small Cell Lung Cancer. Curr Med Sci.
2020;40(1):78-84. (2) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. Over expression of MALAT1 contributes to cervical cancer progression by acting as asponge of miR‐429. 2018. Journal of Cellular Physiology.2019; 234(7);11219-11226. (3) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer. Journal of Cellular Physiology. 2019;234(5):7004-7011. (4) Fujin Shen, Hongyun Zheng*, Limei Zhou, et al. LINC00657 expedites neuropathic pain development by modulating miR-136/ZEB1 axis in a rat model. Journal of cellular biochemistry. J Cell Biochem. 2019;120(1):1000-1010. (5) Hongyun Zheng, Fujin Shen, Yongqing Tong, Yan Li*. PP2A Inhibits cervical cancer cell migration by dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK signaling pathway. Curr Med Sci. 2018;38(1):115-123. (6) Zheng HY, Li Y*, Tong YQ, et al. A novel universal multiplex PCR improves detection of AZFc Y-chromosome microdeletions. Journal of Assisted Reproduction and Genetics. 2014; 31(5):613-20. (7) Zheng H, Li Y, Dai W, et al. Role of Endogenous Estrogen on the Incidence of Coronary Heart Disease in Men. Angiology. 2012; 63(8):591-6. (8) Zheng HY, Li Y*, Dai W, et al. Imbalance of testosterone/estradiol promotes male CHD development. Biomed Mater Eng. 2012; 22(1):179-85. |
武汉大学人民医院
湖北省人民医院